David Farr
Publications by Year
Research Areas
Asthma and respiratory diseases, Receptor Mechanisms and Signaling, Neuropeptides and Animal Physiology, Respiratory and Cough-Related Research, Pharmacological Effects and Assays
Most-Cited Works
- → In Vitro and in Vivo Pharmacological Characterization of 5-[(R)-2-(5,6-Diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-1 H-quinolin-2-one (Indacaterol), a Novel Inhaled β2 Adrenoceptor Agonist with a 24-h Duration of Action(2006)161 cited
- → The Identification of Indacaterol as an Ultralong-Acting Inhaled β2-Adrenoceptor Agonist(2010)100 cited
- → An investigation into the structure–activity relationships associated with the systematic modification of the β2-adrenoceptor agonist indacaterol(2012)32 cited
- → Synthesis and biological properties of novel glucocorticoid androstene C-17 furoate esters(2004)22 cited
- → Potent and selective xanthine-based inhibitors of phosphodiesterase 5(2006)12 cited
- → Suppression of histamine‐induced tachypnoea in the rhesus monkey by sibenadet: no role for dopamine D2 receptors(2004)2 cited
- → The identification of 7-[(R)-2-((1S,2S)-2-benzyloxycyclopentylamino)-1-hydroxyethyl]-4-hydroxybenzothiazolone as an inhaled long-acting β2-adrenoceptor agonist(2014)2 cited
- → CCDC 2248014: Experimental Crystal Structure Determination(2023)
- Discovery of long acting inhaled muscarinic M3 receptor antagonists(2007)